Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma, Malignant × Celecoxib × Clear all

Sponsor

Conditions

Colorectal Neoplasms 7 Breast Neoplasms 6 Head and Neck Neoplasms 4 Adenomatous Polyposis Coli 4 Sarcoma 3 Glioblastoma 3 Colonic Neoplasms 3 Central Nervous System Neoplasms 3 Rectal Neoplasms 2 Paranasal Sinus Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Laryngeal Neoplasms 2 Gliosarcoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Tobacco Use Disorder 1 Stomatitis 1 Smoldering Multiple Myeloma 1 Smoking 1 Recurrence 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Precancerous Conditions 1 Pharyngeal Neoplasms 1 Peritoneal Neoplasms 1 Papilloma 1 Pancreatic Neoplasms 1

Interventions

Pemetrexed 14 Cisplatin 13 pembrolizumab 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiotherapy 3 Gemcitabine 3 Carboplatin 3 cediranib 2 amatuximab 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 sodium thiosulfate 1 sargramostim 1 nintedanib 1 napabucasin 1 methoxyamine 1 liposomal doxorubicin 1 incomplete Freund's adjuvant 1 fresolimumab 1 durvalumab 1 defactinib 1 cixutumumab 1 bintrafusp alfa protein, human 1 bemcentinib 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡